One-Step Preparation of Poly-Lactic-Co-Glycolic-Acid Microparticles to Prevent the Initial Burst Release of Encapsulated Water-Soluble Proteins

Hiroyuki Takabe, Moriyuki Ohkuma, Yasunori Iwao, Shuji Noguchi, Shigeru Itai

Department of Pharmaceutical Engineering, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan..
Drug Formulation Department, Central Research Laboratories, Kaken Pharmaceutical Co., Ltd. Shizuoka, Japan.
Drug Formulation Department, Central Research Laboratories, Kaken Pharmaceutical Co., Ltd. Shizuoka, Japan; Department of Pharmaceutical Engineering, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan..

DOI: 10.4236/pp.2013.48083                

Abstract

An initial burst is often observed during the release of active pharmaceutical ingredients (APIs) from poly-lactic-coglycolic-acid (PLGA) microparticles (MPs) which have been prepared by the emulsion-solvent evaporation method. Herein, we describe the development of a simple one-step coating method that suppresses the initial burst release process. This new method involves coating the PLGA-MPs with PLGA, with the coating process being performed through the phase separation of PLGA on the surface of PLGA-MPs using the emulsion-solvent evaporation method. Bovine serum albumin (BSA) was encapsulated in the PLGA-MPs as a model API. The coated MPs were spherical in shape with no pores on their smooth surface, whereas the non-coated PLGA-MPs had porous surfaces. An in vitro release study showed that the residual levels of BSA in the coated and non-coated PLGA-MPs after 1 h were about 99% and 16% of the original loads, respectively. The one-step coating method therefore represents a useful method for preparing PLGA-MPs that do not give an initial burst release of proteinaceous APIs.

Keywords

Poly-Lactic-Co-Glycolic-Acid; Microparticle; Suppression of Initial Burst Release; Coating; Bovine Serum Albumin

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	R. A. Jain, “The Manufacturing Techniques of Various Drug Loaded Biodegradable Poly(Lactide-Co-Glycolide) (PLGA) Devices,” Biomaterials, Vol. 21, No. 23, 2000, pp. 2475-2490. http://dx.doi.org/10.1016/S0142-9612(00)00115-0
[2]	P. I. P. Park, M. Makoid and S. Jonnalagadda, “The Design of Flexible Ciprofloxacin-Loaded PLGA Implants Using a Reversed Phase Separation/Coacervation Method,” European Journal of Pharmaceutics and Biopharmaceutics, Vol. 77, No. 2, 2011, pp. 233-239. http://dx.doi.org/10.1016/j.ejpb.2010.11.014
[3]	K. Andreas, R. Zehbe, M. Kazubek, K. Grzeschik, N. Sternberg, H. Baumler, H. Schubert, M. Sittinger and J. Ringe, “Biodegradable Insulin-Loaded PLGA Microspheres Fabricated by Three Different Emulsification Techniques: Investigation for Cartilage Tissue Engineering,” Acta Biomaterialia, Vol. 7, No. 4, 2011, pp. 1485-1495. http://dx.doi.org/10.1016/j.actbio.2010.12.014
[4]	C. B. Weldon, J. H. Tsui, S. A. Shankarappa, V. T. Nguyen, M. Ma, D. G. Anderson and D. S. Kohane, “Electrospun Drug-Eluting Sutures for Local Anesthesia,” Journal of Controlled Release, Vol. 161, No. 3, 2012, pp. 903-909. http://dx.doi.org/10.1016/j.jconrel.2012.05.021
[5]	T. Niwa, H. Takeuchi, T. Hino, M. Nohara and Y. Kawashima, “Biodegradable Submicron Carriers for Peptide Drugs: Preparation of dl-Lactide/Glycolide Copolymer (PLGA) Nanospheres with Nafarelin Acetate by a Novel Emulsion-Phase Separation Method in an Oil System,” International Journal of Pharmaceutics, Vol. 121, No. 1, 1995, pp. 45-54. http://dx.doi.org/10.1016/0378-5173(95)00002-Z
[6]	S. Mao, J. Xu, C. Cai, O. Germershaus, A. Schaper and T. Kissel, “Effect of WOW Process Parameters on Morphology and Burst Release of FITC-Dextran Loaded PLGA Microspheres,” International Journal of Pharmaceutics, Vol. 334, No. 1-2, 2007, pp. 137-148. http://dx.doi.org/10.1016/j.ijpharm.2006.10.036
[7]	Y. Yamaguchi, M. Takenaga, A. Kitagawa, Y. Ogawa, Y. Mizushima and R. Igarashi, “Insulin-Loaded Biodegradable PLGA Microcapsules: Initial Burst Release Controlled by Hydrophilic Additives,” Journal of Controlled Release, Vol. 81, No. 3, 2002, pp. 235-249. http://dx.doi.org/10.1016/S0168-3659(02)00060-3
[8]	C. Engineer, J. Parikh and A. Raval, “Effect of Copolymer Ratio on Hydrolytic Degradation of Poly (Lactideco-glycolide) from Drug Eluting Coronary Stents,” Chemical Engineering Research and Design, Vol. 89, No. 3, 2011, pp. 328-334. http://dx.doi.org/10.1016/j.cherd.2010.06.013
[9]	S. Xie, S. Wang, L. Zhu, F. Wang and W. Zhou, “The Effect of Glycolic Acid Monomer Ratio on the Emulsifying Activity of PLGA in Preparation of Protein-Loaded SLN,” Colloids and Surfaces B: Biointerfaces, Vol. 74, No. 1, 2009, pp. 358-361. http://dx.doi.org/10.1016/j.colsurfb.2009.08.005
[10]	B. S. Zolnik and D. J. Burgess, “Evaluation of in Vivo-in Vitro Release of Dexamethasone from PLGA Microspheres,” Journal of Controlled Release, Vol. 127, No. 2, 2008, pp. 137-145. http://dx.doi.org/10.1016/j.jconrel.2008.01.004
[11]	S. S. Chakravarthi and D. H. Robinson, “Enhanced Cellular Association of Paclitaxel Delivered in ChitosanPLGA Particles,” International Journal of Pharmaceutics, Vol. 409, No. 1-2, 2011, pp. 111-120. http://dx.doi.org/10.1016/j.ijpharm.2011.02.034
[12]	M. L. Manca, G. Loy, M. Zaru and A. M. Fadda, “Release of Rifampicin from Chitosan, PLGA and ChitosanCoated PLGA Microparticles,” Colloids and Surfaces B: Biointerfaces, Vol. 67, No. 2, 2008, pp. 166-170. http://dx.doi.org/10.1016/j.colsurfb.2008.08.010
[13]	H. Nojehdehian, F. Moztarzadeh, H. Baharvand, H. Nazarian and M. Tahriri, “Preparation and Surface Characterization of Poly-l-Lysine-Coated PLGA Microsphere Scaffolds Containing Retinoic Acid for Nerve Tissue Engineering: In Vitro Study,” Colloids and Surfaces B: Biointerfaces, Vol. 73, No. 1, 2009, pp. 23-29. http://dx.doi.org/10.1016/j.colsurfb.2009.04.029
[14]	J. Shen and D. J. Burgess, “Accelerated in Vitro Release Testing of Implantable PLGA Microsphere/PVA Hydrogel Composite Coatings,” International Journal of Pharmaceutics, Vol. 422, No. 1-2, 2012, pp. 341-348. http://dx.doi.org/10.1016/j.ijpharm.2011.10.020
[15]	A. Budhian, S. J. Siegel and K. I. Winey, “Controlling the in Vitro Release Profiles for a System of Haloperidol-Loaded PLGA Nanoparticles,” International Journal of Pharmaceutics, Vol. 346, No. 1-2, 2008, pp. 151-159. http://dx.doi.org/10.1016/j.ijpharm.2007.06.011
[16]	A. R. Ahmed, K. Elkharraz, M. Irfan and R. Bodmeier, “Reduction in Burst Release after Coating Poly(d,l-Lactide-Co-Glycolide) (PLGA) Microparticles with a DrugFree PLGA Layer,” Pharmaceutical Development and Technology, Vol. 17, No. 1, 2012, pp. 66-72. http://dx.doi.org/10.3109/10837450.2010.513989
[17]	A. R. Ahmed, A. Dashevsky and R. Bodmeier, “Reduction in Burst Release of PLGA Microparticles by Incorporation into Cubic Phase-Forming Systems,” European Journal of Pharmaceutics and Biopharmaceutics, Vol. 70, No. 3, 2008, pp. 765-769. http://dx.doi.org/10.1016/j.ejpb.2008.07.008
[18]	R. Jeyanthi, R. C. Mehta, B. C. Thanoo and P. P. Deluca, “Effect of Processing Parameters on the Properties of Peptide-Containing PLGA Microspheres,” Journal of Microencapsulation, Vol. 14, No. 2, 1997, pp. 163-174. http://dx.doi.org/10.3109/02652049709015330
[19]	H. K. Makadia and S. J. Siegel, “Poly Lactic-Co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier,” Polymers, Vol. 3, No. 3, 2011, pp. 1377-1397. http://dx.doi.org/10.3390/polym3031377
[20]	G. Mittal, D. K. Sahana, V. Bhardwaj and M. N. V. Ravi Kumar, “Estradiol Loaded PLGA Nanoparticles for Oral Administration: Effect of Polymer Molecular Weight and Copolymer Composition on Release Behavior in Vitro and in Vivo,” Journal of Controlled Release, Vol. 119, No. 1, 2007, pp. 77-85. http://dx.doi.org/10.1016/j.jconrel.2007.01.016